CFO of ONYX Pharmaceuticals Inc. (ONXX, Financial) Matthew K Fust sells 1,919 shares of ONXX on 01/06/2010 at an average price of $29.6 a share.
Onyx Pharmaceuticals Inc. has a market cap of $1.85 billion; its shares were traded at around $29.8 with and P/S ratio of 9.5. Onyx Pharmaceuticals Inc. had an annual average earning growth of 1.3% over the past 5 years.
ONXX is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC, Edward Owens of Vanguard Health Care Fund, Paul Tudor Jones of The Tudor Group, Bruce Kovner of Caxton Associates.
Onyx Pharmaceuticals Inc. has a market cap of $1.85 billion; its shares were traded at around $29.8 with and P/S ratio of 9.5. Onyx Pharmaceuticals Inc. had an annual average earning growth of 1.3% over the past 5 years.
ONXX is in the portfolios of Stanley Druckenmiller of Duquesne Capital Management, LLC, Edward Owens of Vanguard Health Care Fund, Paul Tudor Jones of The Tudor Group, Bruce Kovner of Caxton Associates.
Directors and Officers Recent Trades:
- Sell:: EVP and Chief Business Officer Laura Brege sold 12,500 shares of ONXX stock on 12/02/2009 at the average price of 30, the price of the stock has decreased by 0.67% since.
- Sell:: SVP, Corporate Development Juergen Lasowski sold 3,182 shares of ONXX stock on 08/14/2009 at the average price of 30.73, the price of the stock has decreased by 3.03% since.
- Sell:: EVP and Chief Business Officer Laura Brege sold 25,000 shares of ONXX stock on 07/22/2009 at the average price of 35.9, the price of the stock has decreased by 16.99% since.
- Sell:: VP, Corp. Communication/I.R. Julianna R Wood sold 11,848 shares of ONXX stock on 07/22/2009 at the average price of 35.9, the price of the stock has decreased by 16.99% since.
- Sell:: SVP, Corporate Development Juergen Lasowski sold 8,828 shares of ONXX stock on 07/22/2009 at the average price of 35.98, the price of the stock has decreased by 17.18% since.
